Patient


  • Image attribution tooltip
    AndreyPopov via Getty Images

    Pharmas can be 'more than medicine' by focusing on preventative care

    Why pharma companies are changing their tack to become more than the products they sell.

    By May 24, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    The UK-based company that's striving to overcome the limitations of T cell receptor innovation

    Etcembly’s CEO, Michelle Teng, shares why a platform approach to T cell receptors can advance and democratize innovation.

    By Kim Ribbink • May 23, 2022
  • Image attribution tooltip
    sturti via Getty Images
    Sponsored by ClinicalMind

    3 things medical communications can learn from sales training experts

    Medical communications is moving toward more modern approaches that can make critical information more engaging and better able to "stick".

    May 23, 2022
  • Image attribution tooltip
    John Moore via Getty Images

    A potential COVID-19 EUA could turn this small biotech into a household name

    Veru’s CEO discusses the impact of the upcoming FDA decision on its treatment targeting severely ill COVID-19 patients.

    By May 19, 2022
  • Image attribution tooltip
    Permission granted by SpringWorks/Jim Cassidy
    Profile

    Jumping into pharma with big plans at a small company

    SpringWorks Therapeutics' chief medical officer on the ambition that drives him and his company to develop treatments for cancer patients.

    By Alexandra Pecci • May 17, 2022
  • Image attribution tooltip
    Spencer Platt via Getty Images
    Q&A

    BriOri BioTech sets the stage for the comeback of Vioxx

    With a topical pain-relieving ointment in development, the emerging biotech is aiming to give the tarnished NSAID a new life.

    By Kelly Bilodeau • May 17, 2022
  • Image attribution tooltip
    Stock via Getty Images

    Are digital DCTs the answer for rare diseases?

    How data from EHRs is helping to identify, diagnose and recruit patients to decentralized clinical trials.

    By Kim Ribbink • May 16, 2022
  • Image attribution tooltip
    iStock via Getty Images

    After 40 years, researchers discover new frontiers in the fight against HIV

    Medical advances in the last two decades may now provide scientists with the right toolbox to target the long-elusive virus.

    By May 16, 2022
  • Image attribution tooltip
    Westend61 via Getty Images
    Sponsored by GoodRx

    A better approach to boosting patient engagement

    GoodRx solutions help biopharma brands overcome common barriers & increase patient engagement.

    May 16, 2022
  • Image attribution tooltip

    Sophia Sharp-Donaldson, executive director, Global Strategic Sourcing and Procurement, Kite Pharma and one of this year's HBA Luminary honorees. 

    Opinion

    Why 'soft' skills matter in the new era of leadership

    Standout leaders honored by the Healthcare Businesswomen's Association discuss the rising value of the interpersonal approach.

    By May 12, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: AiCure's Michelle Marlborough

    As chief product officer at AiCure, Michelle Marlborough is focused on solving tough patient challenges through technology.

    By May 11, 2022
  • Image attribution tooltip
    iStock via Getty Images

    It's time to acknowledge access as a prescribing barrier

    A new survey reveals how red tape limits patient access to doctor-preferred specialty drugs. 

    By May 11, 2022
  • Image attribution tooltip
    Sarah Silbiger via Getty Images

    FDA draft guidance may turn diversity in clinical trials from nice-to-have into a must-have

    New guidance from the FDA will ‘up the ante’ for diversity considerations. Here’s how your company can prepare.

    By Kelly Bilodeau • May 10, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    Biotech Spotlight: Everest Medicines takes aim at unmet needs in Asia

    With a multi-pronged business strategy, Everest Medicines is positioning itself as a ‘rising force’ in Asian biotech.

    By May 9, 2022
  • Image attribution tooltip
    iStock via Getty Images

    Pharma's solution to the digital advertising dilemma? Storytelling

    Peter Shin, vice president of Client Services at Sonic Health, says quality storytelling, rather than trendy content, is central to a digital advertising strategy.

    By May 5, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Profile

    From cancer survivor to clinical trial innovator

    How Alicia Staley is using her insights as a three-time cancer survivor to drive clinical trial improvements at Medidata.

    By Kelly Bilodeau • May 3, 2022
  • Image attribution tooltip
    Stock via Getty Images
    Q&A

    One company's failed drug is this company's 'jewel'

    Dr. Thomas Bock, CEO of Notable, is helping the company develop a ‘new class’ of predictive precision medicines in oncology.

    By May 2, 2022
  • Image attribution tooltip

    Permission granted by Laura Randa. 

    Profile

    Laura Randa's aim to break down mental healthcare barriers for disabled patients

    Despite the proliferation of mental health apps, many aren’t accessible for people with disabilities. The CEO of Toivoa plans to change that.

    By Alexandra Pecci • April 27, 2022
  • Image attribution tooltip
    Diego Camargo/PharmaVoice
    Podcast

    Woman of the Week: Gilead Science's Dr. Shanthi Ganeshan

    As vice president of Global Regulatory Affairs, Oncology at Gilead, Ganeshan says there’s ‘never a dull moment’ in the quest to deliver therapies to patients.

    By April 27, 2022
  • Image attribution tooltip
    iStock via Getty Images
    Q&A

    Real-world data is making drug development more true to life

    How RWD is moving from the background to the spotlight in pharma’s development process.

    By Kelly Bilodeau • April 26, 2022
  • Image attribution tooltip

    Permission granted by Ted Love. 

    Profile

    For Global Blood Therapeutics, the connection to sickle cell disease runs deep

    An underserved patient population is a guiding light for the company, which recently scored a new approval.

    By Robin Robinson • April 19, 2022
  • Image attribution tooltip
    Justin Sullivan / Staff via Getty Images
    Q&A

    How pharma can up its social media game

    Health Union’s VP of community development, Sara Hayes, discusses how pharma marketers can better reach online patient communities. 

    By April 18, 2022
  • Image attribution tooltip
    MuseStudio/Shutterstock.com
    Sponsored by Avant Healthcare

    Clinical content that meets the top 3 needs of HCPs

    Learn how to meet the needs of HCPs with clinical content designed to be served up, save time, and satisfy curiosity.

    By Rob Spalding is the Chief Strategy & Marketing Officer at Avant Healthcare • April 18, 2022
  • Image attribution tooltip
    Permission granted by GoodRx
    Sponsored by GoodRx

    Inflation is forcing prioritization of healthcare spending — are you ready?

    Inflation means your customers' money doesn't travel as far as it did a few weeks ago.

    April 18, 2022
  • Image attribution tooltip
    Stock via Getty Images

    What now? Alzheimer's drugmakers ponder the path to approval

    Why Medicare’s unprecedented decision to limit coverage for Aduhelm could have a chilling effect on Alzheimer’s R&D.

    By Kelly Bilodeau • April 14, 2022